EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $172,463 | +17.4% | 16,647 | +33.8% | 0.01% | -14.3% |
| Q4 2022 | $146,893 | -52.5% | 12,438 | -15.5% | 0.01% | -30.0% |
| Q3 2022 | $309,000 | -36.3% | 14,714 | -7.3% | 0.01% | -28.6% |
| Q2 2022 | $485,000 | -24.2% | 15,874 | +3.6% | 0.01% | +7.7% |
| Q1 2022 | $640,000 | -12.8% | 15,319 | -5.8% | 0.01% | -13.3% |
| Q4 2021 | $734,000 | -27.4% | 16,260 | -16.8% | 0.02% | -21.1% |
| Q3 2021 | $1,011,000 | -0.1% | 19,546 | +23.7% | 0.02% | +18.8% |
| Q2 2021 | $1,012,000 | -31.3% | 15,805 | -3.2% | 0.02% | -38.5% |
| Q1 2021 | $1,474,000 | -38.3% | 16,326 | -36.7% | 0.03% | -50.0% |
| Q4 2020 | $2,390,000 | +17.0% | 25,778 | +31.7% | 0.05% | -20.0% |
| Q3 2020 | $2,042,000 | +162.8% | 19,575 | +90.0% | 0.06% | +132.1% |
| Q2 2020 | $777,000 | – | 10,305 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |